Lato Drug Company, Inc. d.b.a. Post Haste Pharmacy
FDA inspection history in Hollywood, Florida, 2020
- 1
- Form 483
Every document, by year
- Form 483
2020: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2020One Form 483, at Hollywood, Florida.
Cited most
Across all Lato Drug Company, Inc. d.b.a. Post Haste Pharmacy observations on file
- 21 CFR 211.165Testing and release for distribution2
- 21 CFR 211.160General requirements1
The complete Lato Drug Company, Inc. d.b.a. Post Haste Pharmacy file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Hollywood, Florida
One Form 483 · 2020 · 3 observations
Latest: Form 483, Feb 20, 2020 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2020-02-20 | 483 Form 483 | Hollywood, Florida | 3 | $99 |
Investigators on these documents
FEI number 3004709093 · most recent document Feb 20, 2020
About Lato Drug Company, Inc. d.b.a. Post Haste Pharmacy
How many FDA Form 483s has Lato Drug Company, Inc. d.b.a. Post Haste Pharmacy received?
FDA Intel has 1 Form 483 on file for Lato Drug Company, Inc. d.b.a. Post Haste Pharmacy; the most recent is dated Feb 20, 2020.
When was Lato Drug Company, Inc. d.b.a. Post Haste Pharmacy last inspected by FDA?
The most recent FDA inspection document on file for Lato Drug Company, Inc. d.b.a. Post Haste Pharmacy is a Form 483 dated Feb 20, 2020, for the site in Hollywood, Florida.
What did FDA cite at Lato Drug Company, Inc. d.b.a. Post Haste Pharmacy?
The regulations cited most in the observations on file for Lato Drug Company, Inc. d.b.a. Post Haste Pharmacy are 21 CFR 211.165 (Testing and release for distribution), 2 times; 21 CFR 211.160 (General requirements), 1 time.